We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+15.22%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$314M
AUM Growth
+$29M
Cap. Flow
-$6.82M
Cap. Flow %
-2.17%
Top 10 Hldgs %
35.88%
Holding
134
New
8
Increased
17
Reduced
65
Closed
7

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.29M
2
AIG icon
American International
AIG
+$1.04M
3
LIN icon
Linde
LIN
+$641K
4
NKE icon
Nike
NKE
+$613K
5
HD icon
Home Depot
HD
+$592K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.65%
2 Technology 17.38%
3 Financials 15.08%
4 Industrials 12.43%
5 Healthcare 11.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
126
McDonald's
MCD
$195B
$204K 0.06%
954
-175
-16% -$38.1K
VTRS icon
127
Viatris
VTRS
$20.6B
$203K 0.06%
+10,859
New +$177K
ALL icon
128
Allstate
ALL
$68.5B
-2,306
Closed -$217K
BF.B icon
129
Brown-Forman Class B
BF.B
$13B
-6,000
Closed -$452K
HAL icon
130
Halliburton
HAL
$26.6B
-12,776
Closed -$154K
PAA icon
131
Plains All American Pipeline
PAA
$16.3B
-11,800
Closed -$71K
SNA icon
132
Snap-on
SNA
$21.7B
-1,800
Closed -$265K
USB icon
133
US Bancorp
USB
$100B
-7,435
Closed -$267K
MMP
134
DELISTED
Magellan Midstream Partners, L.P.
MMP
-6,050
Closed -$207K

Similar funds

EagleClaw Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, EagleClaw Capital Management held 134 positions worth $314M, up 10% from $285M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

EagleClaw Capital Management's Q4 2020 filing shows 8 new, 17 increased, 65 reduced and 7 closed positions. Its largest new stake was ARK Genomic Revolution ETF: 3,930 shares worth $365K. The largest sale was Apple, an estimated $1.29M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • EagleClaw Capital Management's largest Q4 2020 buy was ARK Genomic Revolution ETF: 3,930 shares worth $365K.
  • EagleClaw Capital Management added most to PotlatchDeltic in Q4 2020, an estimated $1.37M increase.
  • EagleClaw Capital Management's biggest Q4 2020 reduction was Apple, cutting an estimated $1.29M.
  • EagleClaw Capital Management fully exited Brown-Forman Class B in Q4 2020, selling an estimated $452K.
  • EagleClaw Capital Management's ten largest holdings make up 36% of its $314M portfolio in Q4 2020.
  • EagleClaw Capital Management opened 8 new positions and closed 7 in Q4 2020.
  • EagleClaw Capital Management's portfolio value rose 10% quarter-over-quarter to $314M.

Based on EagleClaw Capital Management's 13F filing for Q4 2020, filed 11 Feb 2021.